RDY
Dr. Reddy s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com
Tuesday, February 21, 2017 BiopharmaWatch Research 1 min read Key Takeaway: Dr. Reddy s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com
Corporate Relationship Department National Stock Excha
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+8%
120-day peak, hindsight
Typical move
1.3%
average across 4 past catalysts
Lead asset
DFD06
Phase 3 · Psoriasis
Full Press Release Details
| | | Dr. Reddy s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. |
| | | CIN: L85195TG1984PLC004507 |
| | | Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com |
| Corporate Relationship Department | | National Stock Exchange of India Ltd. |
| BSE Limited | | Exchange Plaza |
| Dalal Street, Fort | | Bandra-Kurla Complex, Bandra (East), |
| Mumbai 400 001 | | Mumbai 400 051 |
| Fax Nos.: 022-22723121 / 22723719 / | | Fax Nos.: 022-26598120/ 26598237/ |
| 22722037 / 22722039 | | 26598238 |
| Scrip Code: 500124 | | Scrip Code: DRREDDY-EQ |
This is to inform you that the audit of our API manufacturing plant at Miryalaguda, by the US FDA, has been completed today. We
have been issued a Form 483 with three observations, which we are addressing.
Kindly take the above information on record.
CC:- New York Stock Exchange Inc.(Stock Code: